STRS Ohio’s Audentes Therapeutics, Inc BOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-2,600
Closed -$155K 2139
2019
Q4
$155K Buy
+2,600
New +$97.6K ﹤0.01% 1710
2019
Q1
Sell
-700
Closed -$14K 2136
2018
Q4
$14K Sell
700
-1,100
-61% -$28.4K ﹤0.01% 2010
2018
Q3
$71K Hold
1,800
﹤0.01% 1895
2018
Q2
$68K Hold
1,800
﹤0.01% 1929
2018
Q1
$54K Hold
1,800
﹤0.01% 1730
2017
Q4
$56K Hold
1,800
﹤0.01% 1724
2017
Q3
$50K Hold
1,800
﹤0.01% 1789
2017
Q2
$34K Hold
1,800
﹤0.01% 1846
2017
Q1
$30K Hold
1,800
﹤0.01% 1809
2016
Q4
$32K Hold
1,800
﹤0.01% 1833
2016
Q3
$32K Buy
+1,800
New +$27.3K ﹤0.01% 1813

STRS Ohio's BOLD Position: Q1 2020 in Review

STRS Ohio sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 2,600 shares — an estimated $155K sold.

STRS Ohio first reported a position in BOLD in Q3 2016 and held it in 11 quarters. The position peaked at $155K in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

  • STRS Ohio reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
  • STRS Ohio sold 2,600 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $155K.
  • STRS Ohio first reported a position in Audentes Therapeutics, Inc in Q3 2016 and held it in 11 quarters.
  • STRS Ohio's Audentes Therapeutics, Inc position peaked at $155K in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on STRS Ohio's 13F filing for Q1 2020, filed 23 Apr 2020.